Valproic Acid Solution
FDA Label NDC 0121-0675

47 label sections · Submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Valproic Acid (NDC 0121-0675). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding recent major changes, 1.1 epilepsy, 1.2 important limitations, 2.1 epilepsy, 2.3 dosing in patients taking rufinamide, 3 dosage forms and strengths, 4 contraindications, 5.2 structural birth defects, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.